VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 86 filers reported holding VERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,304,041 | +662.3% | 95,116 | +792.4% | 0.00% | – |
| Q2 2023 | $171,077 | -74.9% | 10,659 | -87.9% | 0.00% | – |
| Q1 2023 | $681,615 | -31.8% | 87,837 | +70.0% | 0.00% | – |
| Q4 2022 | $999,931 | +36.4% | 51,676 | +50.2% | 0.00% | – |
| Q3 2022 | $733,000 | +151.0% | 34,397 | +60.3% | 0.00% | – |
| Q2 2022 | $292,000 | -20.4% | 21,454 | +37.5% | 0.00% | – |
| Q1 2022 | $367,000 | +15.4% | 15,604 | +31.0% | 0.00% | – |
| Q4 2021 | $318,000 | +181.4% | 11,907 | +82.6% | 0.00% | – |
| Q3 2021 | $113,000 | +37.8% | 6,521 | +5.0% | 0.00% | – |
| Q2 2021 | $82,000 | – | 6,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $87,472,500 | 9.83% |
| Kynam Capital Management, LP | 3,000,000 | $48,150,000 | 6.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 975,227 | $15,642,641 | 4.76% |
| Sofinnova Investments, Inc. | 3,467,156 | $55,647,854 | 3.64% |
| Eversept Partners, LP | 1,740,951 | $27,942,264 | 2.34% |
| Altium Capital Management LP | 120,000 | $1,926,000 | 1.46% |
| Carlyle Group Inc. | 2,416,837 | $38,766,065 | 1.38% |
| SECTORAL ASSET MANAGEMENT INC | 351,646 | $5,643,918 | 0.94% |
| Tri Locum Partners LP | 108,928 | $1,748,294 | 0.65% |
| Orbimed Advisors | 1,756,800 | $28,196,640 | 0.51% |